Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 40 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Holding La Pharma from Beveren-Kruibeke-Zwijndrecht, company number BE1021147605, closed financial year 2025 with a result of € 15,136 after tax. For that financial year Holding La Pharma recorded a gross margin of € 257,883 and equity of € 115,136. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 115,136
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 15,136
Profit after tax over the fiscal year.
€ 5,239
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 15,136.
People and assets in 2025
1.9
Average over the fiscal year, from the social balance sheet.
€ 194,102
€ 102,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 749,212
€ 69,821 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 91,836
Supplier invoices still open on the last day of the fiscal year.
€ 77,403
Taxes, VAT and social contributions still to pay.
What happened to Holding La Pharma?
What happened at Holding La Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 15,136. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
- Frederik Derweduwen became a director. NBB
- Maxime Van Eetvelde became a director. NBB
In short
Paid € 6,037 in corporate taxes since 2025.
On average € 135,700 of value added per employee in 2025.
Management
Behind Holding La Pharma are Frederik Derweduwen and Maxime Van Eetvelde. The shares are held by Frederik Derweduwen and Maxime Van Eetvelde. It owns 100% of Apotheek Van Hoorickx itself.
Directors
According to the 2025 annual accounts
since 2025
Maxime Van Eetvelde
Director
Is a shareholder
Also active at: APOTHEEK VAN HOORICKX, Apotheek Maxime Van Eetvelde, Apotheek LA Pharma Groep
since 2025
Shareholders
Frederik Derweduwen · director
Maxime Van Eetvelde · director
Participations
Establishments
Establishment units
Physical locations of this company
Geeraard de Cremerstraat 12
9150 Beveren-Kruibeke-Zwijndrecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VAN EETVELDE Maxime Marleen Godfried(oprichter) 60%
- DERWEDUWEN Frederik(oprichter) 40%
Details
- Company number
- 1021.147.605
- VAT number
- BE 1021.147.605
- Registered office
- Geeraard de Cremerstraat 12, 9150 Beveren-Kruibeke-Zwijndrecht
- Names & denominations
- Holding La Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 March 2025
- Peppol
- Active · Active since 25 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van holdings